ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO170

Pre-Transplant NT-proBNP, Dialysis Duration, and Post-Transplant Mortality in Renal Transplant Recipients

Session Information

Category: Transplantation

  • 1802 Transplantation: Clinical


  • Yeung, Stanley M.H., University Medical Center Groningen, Groningen, Netherlands
  • van Londen, Marco, University Medical Center Groningen, Groningen, Netherlands
  • Nakshbandi, Uzma, UMCG, Groningen, Netherlands
  • Said, Mohammad Yusof, University Medical Center Groningen, Groningen, Netherlands
  • Eisenga, Michele F., University Medical Center Groningen, Groningen, Netherlands
  • Hepkema, Bouke, University Medical Center Groningen, Groningen, Netherlands
  • Nolte, Ilja M., UMCG, Groningen, Netherlands
  • Berger, Stefan P., University of Groningen Medical Center, Groningen, Netherlands
  • De Borst, Martin H., University Medical Center Groningen, Groningen, Netherlands
  • Bakker, Stephan J.L., University Medical Center Groningen, Groningen, Netherlands

Pre-transplant dialysis duration is associated with increased mortality in renal transplant recipients (RTRs) due to intradialytic volume overload and subsequent progression of left ventricular hypertrophy. As a result, the cardiovascular system could deteriorate into a worse state in potential RTRs. N-terminal pro brain natriuretic peptide (NT-proBNP), a protein released by stretch of ventricular cells caused by volume overload, is a prognostic predictor of mortality in end-stage renal disease patients. The aim is to assess if dialysis duration (DD) is independently associated with mortality in RTRs and if NT-proBNP explains the association between DD with mortality in RTRs.


648 patients, transplanted (1995-2005) in the University Medical Center Groningen, were prospectively analyzed after exclusion of 225 patients without sera NT-proBNP and 39 patients with graft failure within 1 year after transplantation. Multivariable Cox regression models were used to study the association of DD and NT-proBNP with all-cause mortality. Mediation analysis was performed to evaluate whether the associations between DD and mortality were mediated by NT-proBNP.


In multivariable Cox regression DD was associated with increased risk for post-transplant mortality, independent of potential confounders including age, gender, creatinine, diastolic blood pressure, diabetic nephropathy, donor type, delayed graft function, pre-emptive transplantation and CMV seropositivity (Hazard ratio [HR]: 1.39; 95% confidence interval [CI]: 1.11-1.75; P=0.004). This association weakened after adjustment for NT-proBNP (HR: 1.25; 95% CI: 0.99-1.58; P=0.06). NT-proBNP was independently associated with all-cause mortality in RTRs (HR: 1.46; 95% CI: 1.23-1.74; P=<0.001). In mediation analysis NT-proBNP was found to explain 47.3% of the effect of DD on all-cause mortality in RTRs.


DD is a predictor of mortality in RTRs and variation in NT-proBNP at the time of transplantation to a large extent captures and mediates the effect of DD on mortality risk in RTRs. Future studies are needed to evaluate the potential value of NT-proBNP as check of cardiac patency of patients on the transplantation waiting list.